Our experience in biotechnology is comprehensive. We have assisted clients with complex IP challenges in the fields of microbiology, vaccines, gene editing technology, antibody therapies, genomics, proteomics, and stem cell therapies.
Our attorneys have acted in key disputes involving CRISPR-Cas9 gene editing technology and developed and implemented protection and FTO strategies to permit the unhindered clinical development of disruptive microbiome therapies.